Applying whole exome sequencing with a family-based design aimed at detecting novel AD risk genes, several rare, missense, and synonymous variants in phospholipase D3 (PLD3) have been reported to be associated with AD risk (Cruchaga et al., 2014). The gene discussed is PLD3; the disease is Alzheimer disease.